脊髓型和传统型多发性硬化症患者激素治疗的临床转归  

Hormone therapy for clinical outcomes in spinal type and conventional multiple sclerosis

作　　者：张慧敏[1] 梁战华[1] 李砺 赵航[1] 

机构地区：[1]大连医科大学附属第一医院神经内科,辽宁大连116011 [2]大连机车医院神经内科,辽宁大连116011

出　　处：《中国医药导报》2011年第19期167-168,共2页China Medical Herald

摘　　要：目的：总结分析脊髓型多发性硬化与传统型多发性硬化的临床特点及激素在缓解期的治疗。方法：回顾分析28例多发性硬化患者临床症状、复发次数、MRI表现及缓解期激素治疗情况。结果：多发性硬化患者以女性居多,典型多发性硬化好发年龄在20~40岁（69.23%）,脊髓型多发性硬化好发年龄在30~50岁（86.66%）;本组中脊髓型多发性硬化占多发性硬化的大部分（53.57%）,脊髓型多发性硬化以颈、胸髓部位病变常见;常规激素治疗脊髓型多发性硬化复发次数明显高于典型多发性硬化。结论：脊髓型多发性硬化常规减停激素治疗复发率较高。Objective：To explore the difference on clinical features between spinal type and conventional multiple sclerosis（MS） and to study the significance of corticosteroid in remission treatment.Methods：According to the retrospective analysis of the 28 cases of MS patients,the clinical manifestation,recurrence rate,magnetic resonance imaging（MRI）,remission of corticosteroids in the treatment results were studied.Results：The patient of MS were female in the majority.The predilection age of conventional MS was 30-50 years old（86.66%）;spinal type MS tooe majority in MS（53.57%）,cervical and thoracic spinal cord were the usual sites;the recurrence rate of conventional MS was lower than spinal type MS.Conclusion：The recurrence rate is higher in spinal type MS when patient are treated with routine hormone.

关 键 词：多发性硬化 脊髓型 皮质类固醇 回顾性分析 

分 类 号：R593.2[医药卫生—内科学]